Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Launched by GALDERMA R&D · Nov 16, 2006

Keywords

ClinConnect Summary

Psoriasis was a chronic disease that was affecting skin, the scalp and joints. Scalp psoriasis was very common and was having an important impact on people's life.

Primary objective of scalp psoriasis treatments was to gain initial and rapid control of the disease process with a minimum of side-effects and improve patient quality of life.

Still, one of the unmet needs of scalp psoriasis therapies was the maintenance of a long-term remission. For corticosteroids in particular, one of the drawbacks was the disease recurrences after cessation of the treatment.

Therefore, the establishment o...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female subjects aged 18 years or older.
• • Subjects with moderate to severe scalp psoriasis
• Exclusion Criteria:
• • Subjects who needed systemic treatment for their body psoriasis
• * Subjects with a washout period for topical treatment(s) on the scalp less than:
• • Corticosteroids 2 weeks
• • All other anti-psoriasis medications 2 weeks
• * Subjects with a washout period for systemic treatment(s) less than:
• • PUVA therapy 4 weeks
• • Biological therapies 12 weeks
• • Treatments other than biologicals with a possible efficacy on psoriasis 4 weeks
• • Treatment known to worsen psoriasis 2 weeks